In the facilitated discussion on the first four questions, several key issues emerged. The summary below captures contributions and questions from all participants, including Minister Bennett.
Safe supply and treatment
To say that safe supply and harm reduction are against treatment is a false narrative. People who are pro-safe supply are pro-treatment, but most importantly they are pro about keeping [themselves and] our families and friends alive. We fully support treatment, especially when it is evidence-based, ethical and non-coercive.
The need for safe supply
People who die are not only those with addiction but include people who use only occasionally or for the first time. People die in greater numbers because the drug supply is becoming increasingly contaminated, especially during COVID19. The longer we wait for regulated supply, the harder, more complex the street drug supply becomes. People use drugs for more reasons than just avoiding withdrawal. People want a safe supply that helps them function. A Safe Supply that the PWUD decides for themselves what success is.
Models of safe supply
We need to expand safe supply to include community models, as people do not deserve to die because the only available responses are medicalized programs. Overwhelming medicalized programs are not what people want to see. Currently, compassion clubs would have to buy on the street or the web and test, as there is no regulated pharmaceutical supply available. Compassion clubs provide a cost-saving to the public health system as people would fund their own supply using the collective purchasing advantage. “We don't want others to pay for our drugs, we want to pay for them. We just don't want to die.”
Smoking options for safe supply
There is not an accessible safe supply for those who prefer smoking and that is who is dying right now. Options for powdered cocaine and morphine are being explored, but there are regulatory implications.
Benzodiazepine contamination
Participants highlighted the greater toxicity of substances that include benzodiazepines and explained that there is increased contamination during COVID19 due to disrupted supply routes. People who use opioids or stimulants do not necessarily seek out benzodiazepines, but have no choice as the substances they buy are contaminated. In a cross-Canada scan conducted by CAPUD, one of the findings is that people have ‘no consent’ to what they are taking - they didn’t consent to the benzos, they consented to opioids. People quickly become use dependent on benzodiazepines and the drug-poisoning response (Naloxone does not reverse Benzo poisoning), as well as withdrawal management, becomes increasingly more difficult. Safe supply alternatives have to be available to people who are using and want to use Benzodiazepine.
Drug Checking/Testing
Drug testing was discussed as a possible solution to a contaminated supply, but it was pointed out that people are going to use the drug anyway, as they can't make a full consented choice when there are no other options. A concern was raised that conservative governments may try to use drug checking as a solution, but it is not an alternative to safe supply. Drug testing needs to go hand in hand with real safe supply. Drug testing is more effective for party substances where people have a choice not to use when there is contamination. Buyers' clubs are so important because of the quality of drug checking and then people will know what they are getting.
Safe supply outside of the BC Lower Mainland and Ontario
In much of the country, especially in the north, safe supply is not available and opioid agonist treatment (OAT) is often equated with safe supply. Governments refuse to provide funding, even vilify safe supply (prairie region).
Safe supply is a reconciliation issue and Indigenous people, much like the ACB community, are disproportionately affected by toxic drugs. The north, rural and remote can’t be left behind, because right now they are in crisis.
What is needed and how do we move forward?
There is a lack of consultation with PWUD by provincial and regional actors and this needs to change to move forward. It is essential that the federal government hold the provinces/territories accountable for being authentic with any program funding they provide. We see provinces announce programs that are not implemented or if implemented not in the way in which they were intended. We need a commitment from the federal government to have clear benchmarks attached to payments to provinces.
The BC Coroners Report released on March 9, 2022, highlights that people are dying from a toxic drug supply and that safe supply is urgently needed to stop the dying.
The important question we need to ask is not if we should do this [safe supply] but how!
Safe supply models need to be developed from the bottom up with people who use drugs leading the way. We need to hold a rigorous design process across the country to find the best way to create safe supply and we need much stronger leadership at the federal level to make this happen. People who use drugs, represented by CAPUD and other organizations need to be at the design table in all regions of the country. This needs to include a strong voice from the ACB and the Indigenous community.
The panel discussed if the term regulated supply would be a better term than safe supply. There was agreement that regulation with a public health focus should be the aim, and preferred terminology should be explored with people who use drugs.
The discussion concluded with the presentation of the key recommendations noted above. All participants, including Minister Bennett, agreed that there was an urgent need to meet again and to continue this important conversation.
Closing remarks were provided by Petra Schulz who asked all participants to remember the In the thousands we mourn and read statements families used to describe their loved ones. One thousand such statements were collected in the See-Beyond project, in collaboration with Dr. Rebecca Haines Saah.